BR0111567A - Ligandos do receptor de melanocortina - Google Patents

Ligandos do receptor de melanocortina

Info

Publication number
BR0111567A
BR0111567A BR0111567-7A BR0111567A BR0111567A BR 0111567 A BR0111567 A BR 0111567A BR 0111567 A BR0111567 A BR 0111567A BR 0111567 A BR0111567 A BR 0111567A
Authority
BR
Brazil
Prior art keywords
melanocortin receptor
receptor ligands
melanocortin
het
disorders
Prior art date
Application number
BR0111567-7A
Other languages
English (en)
Inventor
Philip Albert Carpino
Bridget Mccarthy Cole
Bradley Paul Morgan
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR0111567A publication Critical patent/BR0111567A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"LIGANDOS DO RECEPTOR DE MELANOCORTINA". em que R^ 3^, R^ 4^, R^ 6^, R^ 7^, X^ 4^ Q e HET são conforme acima definidos, útil para o tratamento ou prevenção de desordens, doenças ou condições responsivas à ativação do receptor de melanocortina.
BR0111567-7A 2000-06-28 2001-05-31 Ligandos do receptor de melanocortina BR0111567A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21461600P 2000-06-28 2000-06-28
PCT/IB2001/000995 WO2002000654A1 (en) 2000-06-28 2001-05-31 Melanocortin receptor ligands

Publications (1)

Publication Number Publication Date
BR0111567A true BR0111567A (pt) 2003-05-06

Family

ID=22799775

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0111567-7A BR0111567A (pt) 2000-06-28 2001-05-31 Ligandos do receptor de melanocortina

Country Status (26)

Country Link
US (1) US20020072604A1 (pt)
EP (1) EP1294719A1 (pt)
JP (1) JP2004501917A (pt)
KR (1) KR20030017571A (pt)
CN (1) CN1440406A (pt)
AP (1) AP2001002196A0 (pt)
AR (1) AR030301A1 (pt)
AU (1) AU2001260548A1 (pt)
BG (1) BG107268A (pt)
BR (1) BR0111567A (pt)
CA (1) CA2412563A1 (pt)
EA (1) EA200201119A1 (pt)
EC (1) ECSP024404A (pt)
IL (1) IL152781A0 (pt)
IS (1) IS6617A (pt)
MA (1) MA26920A1 (pt)
MX (1) MXPA03000063A (pt)
NO (1) NO20026280L (pt)
OA (1) OA12296A (pt)
PA (1) PA8521501A1 (pt)
PE (1) PE20020208A1 (pt)
PL (1) PL360855A1 (pt)
TN (1) TNSN01097A1 (pt)
UY (1) UY26804A1 (pt)
WO (1) WO2002000654A1 (pt)
ZA (1) ZA200210277B (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1289526A4 (en) * 2000-05-30 2005-03-16 Merck & Co Inc MELANOCORTIN RECEPTOR AGONISTS
HUP0401544A2 (hu) 2001-03-02 2004-12-28 Bristol-Myers Squibb Company Melanokortin receptor modulátoraiként hasznos vegyületek és a vegyületeket tartalmazó gyógyszerkészítmények
US6911447B2 (en) 2001-04-25 2005-06-28 The Procter & Gamble Company Melanocortin receptor ligands
US7718802B2 (en) 2001-08-10 2010-05-18 Palatin Technologies, Inc. Substituted melanocortin receptor-specific piperazine compounds
US7354923B2 (en) * 2001-08-10 2008-04-08 Palatin Technologies, Inc. Piperazine melanocortin-specific compounds
US7655658B2 (en) * 2001-08-10 2010-02-02 Palatin Technologies, Inc. Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds
AU2002331064B2 (en) * 2001-08-10 2007-08-23 Palatin Technologies, Inc. Peptidomimetics of biologically active metallopeptides
US7456184B2 (en) * 2003-05-01 2008-11-25 Palatin Technologies Inc. Melanocortin receptor-specific compounds
US7732451B2 (en) * 2001-08-10 2010-06-08 Palatin Technologies, Inc. Naphthalene-containing melanocortin receptor-specific small molecule
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
AU2002352878B2 (en) 2001-11-27 2007-11-22 Merck Sharp & Dohme Corp. 2-Aminoquinoline compounds
US7026335B2 (en) 2002-04-30 2006-04-11 The Procter & Gamble Co. Melanocortin receptor ligands
US7132539B2 (en) 2002-10-23 2006-11-07 The Procter & Gamble Company Melanocortin receptor ligands
CA2515717A1 (en) 2003-02-10 2004-08-19 Banyu Pharmaceutical Co., Ltd. Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient
US7727991B2 (en) 2003-05-01 2010-06-01 Palatin Technologies, Inc. Substituted melanocortin receptor-specific single acyl piperazine compounds
US7727990B2 (en) 2003-05-01 2010-06-01 Palatin Technologies, Inc. Melanocortin receptor-specific piperazine and keto-piperazine compounds
US7968548B2 (en) 2003-05-01 2011-06-28 Palatin Technologies, Inc. Melanocortin receptor-specific piperazine compounds with diamine groups
JP2005306839A (ja) * 2003-08-29 2005-11-04 Takeda Chem Ind Ltd 二環性ピペラジン化合物およびその用途
US7795267B2 (en) 2003-08-29 2010-09-14 Takeda Pharmaceutical Company Limited Bicyclic piperazine compound having TGR23 antagonistic activity
KR101092716B1 (ko) * 2004-04-08 2011-12-09 아스테라스 세이야쿠 가부시키가이샤 화합물 ｗｓ727713
US7709484B1 (en) 2004-04-19 2010-05-04 Palatin Technologies, Inc. Substituted melanocortin receptor-specific piperazine compounds
CN101257916B (zh) * 2005-07-08 2013-04-03 益普生制药股份有限公司 黑皮质素受体配体
PL1912650T3 (pl) 2005-08-03 2018-01-31 Sprout Pharmaceuticals Inc Zastosowanie flibanseryny w leczeniu otyłości
CA2626134C (en) 2005-10-29 2013-12-24 Boehringer Ingelheim International Gmbh Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
PE20080145A1 (es) * 2006-03-21 2008-02-11 Janssen Pharmaceutica Nv Tetrahidro-pirimidoazepinas como moduladores de trpv1
JP2009541443A (ja) 2006-06-30 2009-11-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 尿失禁及び関連疾患の治療のためのフリバンセリン
JPWO2008007664A1 (ja) * 2006-07-11 2009-12-10 武田薬品工業株式会社 二環性複素環化合物およびその用途
US7834017B2 (en) 2006-08-11 2010-11-16 Palatin Technologies, Inc. Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituents
JP5793828B2 (ja) 2006-08-14 2015-10-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング フリバンセリンの製剤及びその製造方法
EP2056797A2 (en) 2006-08-25 2009-05-13 Boehringer Ingelheim International GmbH Controlled release system and method for manufacturing the same
ES2618315T3 (es) 2007-05-25 2017-06-21 Ipsen Pharma S.A.S. Ligandos del receptor de melanocortina modificados con hidantoína
CL2008002693A1 (es) 2007-09-12 2009-10-16 Boehringer Ingelheim Int Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad
PE20091102A1 (es) 2007-12-17 2009-07-25 Janssen Pharmaceutica Nv Moduladores imidazolo-, oxazolo-, y tiazolopirimidina del trpv1

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999055679A1 (en) * 1998-04-28 1999-11-04 Trega Biosciences, Inc. Isoquinoline compound melanocortin receptor ligands and methods of using same
JP2002517444A (ja) * 1998-06-11 2002-06-18 メルク エンド カムパニー インコーポレーテッド メラノコルチン受容体作動薬としてのスピロピペリジン誘導体
WO2000074679A1 (en) * 1999-06-04 2000-12-14 Merck & Co., Inc. Substituted piperidines as melanocortin-4 receptor agonists

Also Published As

Publication number Publication date
ZA200210277B (en) 2003-12-19
PA8521501A1 (es) 2002-10-24
NO20026280D0 (no) 2002-12-30
BG107268A (en) 2003-06-30
TNSN01097A1 (fr) 2005-11-10
UY26804A1 (es) 2002-01-31
MA26920A1 (fr) 2004-12-20
AR030301A1 (es) 2003-08-20
NO20026280L (no) 2002-12-30
PE20020208A1 (es) 2002-03-13
CA2412563A1 (en) 2002-01-03
EP1294719A1 (en) 2003-03-26
MXPA03000063A (es) 2003-09-25
AP2001002196A0 (en) 2002-12-21
IL152781A0 (en) 2003-06-24
JP2004501917A (ja) 2004-01-22
PL360855A1 (en) 2004-09-20
CN1440406A (zh) 2003-09-03
US20020072604A1 (en) 2002-06-13
IS6617A (is) 2002-11-14
KR20030017571A (ko) 2003-03-03
OA12296A (en) 2006-05-12
WO2002000654A1 (en) 2002-01-03
AU2001260548A1 (en) 2002-01-08
EA200201119A1 (ru) 2003-06-26
ECSP024404A (es) 2003-02-06

Similar Documents

Publication Publication Date Title
BR0111567A (pt) Ligandos do receptor de melanocortina
ATE314371T1 (de) Spiro-indole als y5-rezeptor antagonisten
BR9910832A (pt) Agonistas de receptores "beta" 2-adrenérgicos
BRPI0409701A (pt) ligantes de receptores de canabinóides e seus usos
DK1196172T3 (da) (S,S)-reboxetin til behandling af kronisk smerte
IS6350A (is) ß2-adrenvirk viðtaka gerandefni
TR200101859T2 (tr) Kemokin alıcı aktivitesinin modülatörleri olarak N-üreidoalkil-piperidinler
BRPI0411078A (pt) ligantes de receptores de canabinóides e seus usos
WO1999054326A8 (de) Dihydropyrimidine
CO4910133A1 (es) Antagonistas de 5-h[1f]
TR199900318T2 (xx) IL-8 resept�r antagonistleri.
BR0309095A (pt) Uso de osteoprotegerina para o tratamento e/ou prevenção de doença fibrótica
DK1056454T3 (da) Anvendelse af makrolidforbindelser til behandling af glaukom
PT1300084E (pt) Composicaio para o tratamento de insuficiencias venosas cronicas melha.
DE60025639D1 (de) Substituierte diazepan
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
DK1223930T3 (da) Behandling af dyskinesi
WO2002060382A3 (en) Novel compounds and uses thereof
DK1152760T3 (da) Anvendelse af 4-aminopyridin til behandling af perifere neuropatier
TR200003203T2 (tr) Karboksaldehitin saflaştırılması
BR0111074A (pt) N-hidroxiformamidas biciclil ou heterobiciclilme-tanossulfonilamino-substituìdos
DK1459748T3 (da) (S,S)-reboxetin til behandling af perifer neuropati
DK1121108T3 (da) Ny terapeutisk anvendelse af forbindelser med beta-3-agonistaktivitet
DK1366033T3 (da) Kemiske forbindelser
AU6121901A (en) Felbamate derived compounds

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 6A., 7A. E 8A. ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2008 DE 30/06/2009.